Open AccessJournal Article
Diabetic autonomic neuropathy
Reads0
Chats0
About:
This article is published in Atencion Primaria.The article was published on 1989-12-01 and is currently open access. It has received 849 citations till now. The article focuses on the topics: Diabetic Autonomic Neuropathy.read more
Citations
More filters
Journal ArticleDOI
Standards of Medical Care in Diabetes—2012
TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payers, and other interested individuals with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care.
Journal ArticleDOI
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
TL;DR: This review focuses on various potential applications of supramolecular hydrogels as molecular biomaterials, classified by their applications in cell cultures, tissue engineering, cell behavior, imaging, and unique applications of hydrogelators.
Journal ArticleDOI
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
Rodica Pop-Busui,Andrew J.M. Boulton,Eva L. Feldman,Vera Bril,Roy Freeman,Rayaz A. Malik,Jay M. Sosenko,Dan Ziegler +7 more
TL;DR: Although screening for rarer atypical forms of diabetic neuropathy may be warranted, DSPN and autonomic neuropathy are the most common forms encountered in practice and the strongest available evidence regarding treatment pertains to these forms.
Journal ArticleDOI
Diabetic Cardiovascular Autonomic Neuropathy
Aaron I. Vinik,Dan Ziegler +1 more
TL;DR: The present report discusses the clinical manifestations (eg, resting tachycardia, orthostasis, exercise intolerance, intraoperative cardiovascular liability, silent myocardial infarction [MI], and increased risk of mortality), and demonstrates that autonomic dysfunction can affect daily activities of individuals with diabetes and may invoke potentially life-threatening outcomes.
Journal ArticleDOI
Standards of medical care in diabetes--2006: response to the American Diabetes Association.
TL;DR: In regard to the ADA’s recommendation to use statin therapy for diabetic patients without overt cardiovascular disease (CVD), the recommendation to treat “regardless of baseline LDL” might have extended beyond the evidence quoted.
References
More filters
Journal ArticleDOI
Standards of Medical Care in Diabetes—2012
TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payers, and other interested individuals with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care.
Journal ArticleDOI
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
TL;DR: This review focuses on various potential applications of supramolecular hydrogels as molecular biomaterials, classified by their applications in cell cultures, tissue engineering, cell behavior, imaging, and unique applications of hydrogelators.
Journal ArticleDOI
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
Rodica Pop-Busui,Andrew J.M. Boulton,Eva L. Feldman,Vera Bril,Roy Freeman,Rayaz A. Malik,Jay M. Sosenko,Dan Ziegler +7 more
TL;DR: Although screening for rarer atypical forms of diabetic neuropathy may be warranted, DSPN and autonomic neuropathy are the most common forms encountered in practice and the strongest available evidence regarding treatment pertains to these forms.
Journal ArticleDOI
Diabetic Cardiovascular Autonomic Neuropathy
Aaron I. Vinik,Dan Ziegler +1 more
TL;DR: The present report discusses the clinical manifestations (eg, resting tachycardia, orthostasis, exercise intolerance, intraoperative cardiovascular liability, silent myocardial infarction [MI], and increased risk of mortality), and demonstrates that autonomic dysfunction can affect daily activities of individuals with diabetes and may invoke potentially life-threatening outcomes.
Journal ArticleDOI
Standards of medical care in diabetes--2006: response to the American Diabetes Association.
TL;DR: In regard to the ADA’s recommendation to use statin therapy for diabetic patients without overt cardiovascular disease (CVD), the recommendation to treat “regardless of baseline LDL” might have extended beyond the evidence quoted.